Skip to main content
Clinical Trials/ISRCTN17473023
ISRCTN17473023
Active, Not Recruiting
N/A

Colorectal Cancer Cohort Study (COLO-COHORT)

South Tyneside and Sunderland NHS Foundation Trust0 sites15,000 target enrollmentDecember 23, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Colorectal neoplasia, colorectal cancer
Sponsor
South Tyneside and Sunderland NHS Foundation Trust
Enrollment
15000
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 23, 2019
End Date
January 14, 2036
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
South Tyneside and Sunderland NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \=30 years and able to give informed consent
  • 2\. Patients attending colonoscopy:
  • 2\.1 Through Bowel Cancer Screening Programme (FIT positive, Bowelscope conversion, surveillance)
  • 2\.2 Through standard NHS care (most commonly due to iron deficiency anaemia, altered bowel habit, weight loss, rectal bleeding, planned polypectomy, those referred on basis of family history, abnormal cross\-sectional imaging, polyp surveillance or post CRC surveillance)
  • (COLO\-SPEED) Group B:
  • 1\. Any patient attending for colonoscopy and able to give informed consent
  • 2\. At least 18 years old
  • 3\. In a centre supported by COLO\-SPEED infrastructure (i.e. in North of England)

Exclusion Criteria

  • 1\. Unable to give informed consent
  • 2\. Known polyposis syndrome
  • 3\. Previous total colectomy
  • 4\. Known colonic stricture which would limit complete colonoscopy
  • 5\. Attending for planned therapeutic procedure other than polypectomy, such as insertion of colonic stent
  • 6\. Attending for assessment of known inflammatory bowel disease (IBD) activity or for IBD surveillance
  • 7\. Patients currently recruited into an interventional CTIMP for CRC prevention
  • COLO\-SPEED (Group B):
  • 1\. DOes not meet inclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
COLON-study Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that influence colorectal tumour recurrence, survival and quality of lifecolorectal cancer10017991
NL-OMON32845Wageningen Universiteit1,000
Completed
N/A
Vitamin C for Colorectal Cancer: A clinical window study to assess high dose vitamin C administration in colorectal cancer patientsColorectal cancerCancer - Bowel - Back passage (rectum) or large bowel (colon)
ACTRN12615001277538Prof Margreet Vissers12
Recruiting
N/A
Prospective observational study of colorectal cancer examining diagnosis opportunity and risk factors, CRC-DR study
JPRN-UMIN000051316Kyoto Prefectural University of Medicine1,000
Active, Not Recruiting
Phase 1
A study for people with advanced colorectal cancer who have been treated with a specific chemotherapy regimen (Bevacizumab, Oxaliplatin, and a Fluoropyrimidine) which was ineffective in stopping the spread of the colorectal cancer. Study participants will receive a different chemotherapy regimen (Irinotecan, Folinic Acid, and 5-Fluorouracil) and be randomly and unknowingly assigned to also receive the study drug (ramucirimab) or a non-active compound (placebo).Metastatic Colorectal CancerMedDRA version: 17.0Level: LLTClassification code 10010036Term: Colorectal carcinomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2010-021037-32-DEEli Lilly and Company Limited, Indianapolis1,050
Not Yet Recruiting
N/A
Evaluation of Colorectal neoplasia(s) incidence in Bariatric Surgery CandidatesObesitycolorectal neoplasiacolorectal cancerscreening colonoscopyDiet and Nutrition - ObesityCancer - Bowel - Back passage (rectum) or large bowel (colon)
ACTRN12620000120976Mehmet Ali Yerdel200